Malignant Pleural Mesothelioma: ESMO Clinical Practice Guidelines

Published in 2015 – Ann Oncol (2015) 26 (suppl 5): v31-v39.
Authors: P. Baas, D. Fennell, K. M. Kerr, P. E. Van Schil, R. L. Haas, S. Peters

Malignant pleural mesothelioma (MPM) is considered to be a relatively rare tumour, although incidence has increased during the last ten years. The updated ESMO Clinical Practice Guidelines provide clear recommendations for management of this disease from diagnosis through treatment (medical, radiotherapy and surgery) to follow up.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings